Study to Evaluate GSK2190915 in Subjects With Mild Asthma
NCT00812773
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
GSK2190915
Sponsor
GlaxoSmithKline